Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau

IntroductionDue to its high transmissibility and immune escape, Omicron subvariant BA.5 has become the dominant strain of the SARS-CoV-2 virus and led to escalating COVID-19 cases, how to cope with it becomes an urgent issue. A BA.5 infection surge burst out on 18 June 2022 and brought an unpreceden...

Full description

Bibliographic Details
Main Authors:	Cong Xu, Jue Wang, Lili Yu, Xinbing Sui, Qibiao Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Public Health
Subjects:	successful experience Macau Omicron subvariant BA.5 “relatively static” strategy anti-COVID-19 containable
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.1029171/full

Similar Items

Mapping the Early Dispersal Patterns of SARS-CoV-2 Omicron BA.4 and BA.5 Subvariants in the Absence of Travel Restrictions and Testing at the Borders in Europe
by: Evangelia Georgia Kostaki, et al.
Published: (2022-12-01)

Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study
by: Denggao Peng, et al.
Published: (2022-07-01)

Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January–March 2022
by: Daniela Loconsole, et al.
Published: (2022-04-01)

Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
by: Huiyun Peng, et al.
Published: (2023-04-01)

Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study
by: Carson K. L. Lo, et al.
Published: (2024-01-01)

Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study
by: Jie Li, et al.
Published: (2023-08-01)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022-12-01)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
by: Hanzhong Ke, et al.
Published: (2022-09-01)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
by: Xue-Jun Wang, et al.
Published: (2022-12-01)

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
by: Panke Qu, et al.
Published: (2023-02-01)

Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review
by: Shaheen N, et al.
Published: (2022-10-01)

Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
by: Yaning Li, et al.
Published: (2023-06-01)

Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5
by: Yu WU, Jue LIU, Min LIU, Wannian LIANG
Published: (2022-10-01)

Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort
by: Jianliang Huang, et al.
Published: (2023-10-01)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
by: Chiranjib Chakraborty, et al.
Published: (2023-03-01)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023-06-01)

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay
by: Mako Toyoda, et al.
Published: (2023-08-01)

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractResearch in context
by: Bingjie Hu, et al.
Published: (2024-01-01)

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
by: Revansiddha H. Katte, et al.
Published: (2024-03-01)

Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China
by: Xiaofeng He, et al.
Published: (2024-01-01)

Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2
by: Jianguo Li, et al.
Published: (2022-08-01)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
by: Alexander Wilhelm, et al.
Published: (2022-08-01)

High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2
by: Takuro Koshikawa, et al.
Published: (2022-09-01)

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study
by: Cheng Cao, et al.
Published: (2023-08-01)

XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness
by: Okesanya Olalekan John, B'MLS, et al.
Published: (2023-12-01)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
by: Shuai Xia, et al.
Published: (2023-12-01)

MACAU NO DIÁLOGO CULTURAL COM O ORIENTE
by: Jorge Rangel
Published: (1993-12-01)

Computational Investigation of Selected Spike Protein Mutations in SARS-CoV-2: Delta, Omicron, and Some Circulating Subvariants
by: Urmi Roy
Published: (2023-12-01)

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
by: Samuel M.S. Cheng, et al.
Published: (2024-03-01)

COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2
by: Wei-Chun Chen, et al.
Published: (2023-08-01)

Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay
by: Akira Aoki, et al.
Published: (2022-10-01)

The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children
by: Djatnika Setiabudi, et al.
Published: (2022-08-01)

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
by: Jéssica Pires Farias, et al.
Published: (2023-12-01)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022-11-01)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2023-02-01)

Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
by: Norika Nagasawa, et al.
Published: (2023-09-01)

The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
by: Dandan Tian, et al.
Published: (2022-10-01)

Violence and interpretation, readings of the history of Macau
by: Mário César Lugarinho
Published: (2018-06-01)

Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark
by: Kimihito Ito, et al.
Published: (2022-06-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
by: Maarten E. Emmelot, et al.
Published: (2022-12-01)